Steffen Thomas
CIK: 0001646396
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVXL
ANAVEX LIFE SCIENCES CORP.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 5, 2025AVXL
ANAVEX LIFE SCIENCES CORP.
Exercise(M)Direct50K shares at avg. $1.76$88K - Jun 5, 2025AVXL
ANAVEX LIFE SCIENCES CORP.
Tax Payment(F)Direct11.3K shares at avg. $7.75$88K - Mar 31, 2025AVXL
ANAVEX LIFE SCIENCES CORP.
Award(A)DirectStock Option (Right to Buy)
50K shares-
1-3 of 3 transactions
About Thomas Steffen
Thomas Steffen (SEC CIK 0001646396) files insider reports with the SEC as Director of ANAVEX LIFE SCIENCES CORP. (AVXL).
Signal8 holds 2 ownership filings by Thomas Steffen, all Form 4s, filed between Apr 2, 2025 and Jun 9, 2025. Those filings report 3 transactions, from Mar 31, 2025 to Jun 5, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Thomas Steffen's filings is in NEW YORK, NY.
Recent filings by Thomas Steffen
Other insiders filing for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Senderowicz Adrian, Director
- Patel Gautam, Director
- Boenisch Sandra, PFO & Treasurer
- Kellmeyer Terrie, Interim CEO
- Paeger Axel, Director
- MISSLING CHRISTOPHER U, President and CEO